293 related articles for article (PubMed ID: 15854163)
61. Functional alterations in endothelial NO, PGI₂ and EDHF pathways in aorta in ApoE/LDLR-/- mice.
Csányi G; Gajda M; Franczyk-Zarow M; Kostogrys R; Gwoźdź P; Mateuszuk L; Sternak M; Wojcik L; Zalewska T; Walski M; Chlopicki S
Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):107-15. PubMed ID: 22465673
[TBL] [Abstract][Full Text] [Related]
62. Vasorelaxation induced by vascular endothelial growth factor in the human internal mammary artery and radial artery.
Wei W; Chen ZW; Yang Q; Jin H; Furnary A; Yao XQ; Yim AP; He GW
Vascul Pharmacol; 2007 Apr; 46(4):253-9. PubMed ID: 17174609
[TBL] [Abstract][Full Text] [Related]
63. The endothelium in health and disease: A discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.
Triggle CR; Ding H; Anderson TJ; Pannirselvam M
Mol Cell Biochem; 2004 Aug; 263(1):21-7. PubMed ID: 27520662
[TBL] [Abstract][Full Text] [Related]
64. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries.
Mather S; Dora KA; Sandow SL; Winter P; Garland CJ
Circ Res; 2005 Aug; 97(4):399-407. PubMed ID: 16037574
[TBL] [Abstract][Full Text] [Related]
65. Role of NO and EDHF-mediated endothelial function in the porcine pulmonary circulation: comparison between pulmonary artery and vein.
Zhang RZ; Yang Q; Yim AP; Huang Y; He GW
Vascul Pharmacol; 2006 Mar; 44(3):183-91. PubMed ID: 16448859
[TBL] [Abstract][Full Text] [Related]
66. Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone.
Ellis A; Triggle CR
Can J Physiol Pharmacol; 2003 Nov; 81(11):1013-28. PubMed ID: 14719036
[TBL] [Abstract][Full Text] [Related]
67. Endothelial control of vascular tone by nitric oxide and gap junctions: a haemodynamic perspective.
Griffith TM
Biorheology; 2002; 39(3-4):307-18. PubMed ID: 12122246
[TBL] [Abstract][Full Text] [Related]
68. Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice.
Gaubert ML; Sigaudo-Roussel D; Tartas M; Berrut G; Saumet JL; Fromy B
J Physiol; 2007 Dec; 585(Pt 2):617-26. PubMed ID: 17932144
[TBL] [Abstract][Full Text] [Related]
69. Which endothelium-derived factors are really important in humans?
Taddei S; Virdis A; Ghiadoni L; Versari D; Salvetti A
Biol Chem; 2006 Feb; 387(2):151-7. PubMed ID: 16497146
[TBL] [Abstract][Full Text] [Related]
70. [Endothelium-derived hyperpolarizing factor and endothelium dysfunction].
Takaki A; Shimokawa H
Nihon Rinsho; 2006 Jul; 64 Suppl 5():240-3. PubMed ID: 16895189
[No Abstract] [Full Text] [Related]
71. Adenosine instead of supranormal potassium in cardioplegic solution preserves endothelium-derived hyperpolarization factor-dependent vasodilation.
Jakobsen O; Stenberg TA; Losvik O; Ekse S; Sørlie DG; Ytrebø LM
Eur J Cardiothorac Surg; 2008 Jan; 33(1):18-24. PubMed ID: 18042395
[TBL] [Abstract][Full Text] [Related]
72. Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds.
Xu Y; Henning RH; van der Want JJ; van Buiten A; van Gilst WH; Buikema H
Life Sci; 2007 Apr; 80(18):1678-85. PubMed ID: 17335855
[TBL] [Abstract][Full Text] [Related]
73. Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells.
Saliez J; Bouzin C; Rath G; Ghisdal P; Desjardins F; Rezzani R; Rodella LF; Vriens J; Nilius B; Feron O; Balligand JL; Dessy C
Circulation; 2008 Feb; 117(8):1065-74. PubMed ID: 18268148
[TBL] [Abstract][Full Text] [Related]
74. Gender difference in the role of endothelium-derived relaxing factors modulating renal vascular reactivity.
Wangensteen R; Moreno JM; Sainz J; Rodríguez-Gómez I; Chamorro V; Luna Jde D; Osuna A; Vargas F
Eur J Pharmacol; 2004 Feb; 486(3):281-8. PubMed ID: 14985050
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of superoxide anion-mediated impairment of endothelium by treatment with luteolin and apigenin in rat mesenteric artery.
Ma X; Li YF; Gao Q; Ye ZG; Lu XJ; Wang HP; Jiang HD; Bruce IC; Xia Q
Life Sci; 2008 Jul; 83(3-4):110-7. PubMed ID: 18558413
[TBL] [Abstract][Full Text] [Related]
76. The endothelium-derived hyperpolarizing factor: insights from genetic animal models.
Köhler R; Hoyer J
Kidney Int; 2007 Jul; 72(2):145-50. PubMed ID: 17457372
[TBL] [Abstract][Full Text] [Related]
77. The endothelium in health and disease--a target for therapeutic intervention.
Triggle CR; Hollenberg M; Anderson TJ; Ding H; Jiang Y; Ceroni L; Wiehler WB; Ng ES; Ellis A; Andrews K; McGuire JJ; Pannirselvam M
J Smooth Muscle Res; 2003 Dec; 39(6):249-67. PubMed ID: 15048017
[TBL] [Abstract][Full Text] [Related]
78. The significance of endothelium-derived hyperpolarizing factor in the human circulation.
Yang Q; Yim AP; He GW
Curr Vasc Pharmacol; 2007 Jan; 5(1):85-92. PubMed ID: 17266616
[TBL] [Abstract][Full Text] [Related]
79. [Therapeutic target for endothelium-derived hyperpolarizing factor signaling in diabetic vascular complication].
Matsumoto T
Yakugaku Zasshi; 2010 Jun; 130(6):777-84. PubMed ID: 20519855
[TBL] [Abstract][Full Text] [Related]
80. Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes.
Shi Y; Vanhoutte PM
J Diabetes; 2009 Sep; 1(3):151-62. PubMed ID: 20923534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
